cyclothiazide has been researched along with 6-(1h-imidazol-1-yl)-7-nitro-2,3(1h,4h)-quinoxalinedione in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ohno, K; Okada, M; Sakamoto, S; Tsutsumi, R; Yamaguchi, T | 1 |
1 other study(ies) available for cyclothiazide and 6-(1h-imidazol-1-yl)-7-nitro-2,3(1h,4h)-quinoxalinedione
Article | Year |
---|---|
The AMPA-receptor antagonist YM90K reduces AMPA receptor-mediated excitotoxicity in rat hippocampal cultures.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Benzothiadiazines; Cells, Cultured; Diuretics; Drug Interactions; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Hippocampus; Kainic Acid; Neurons; Neuroprotective Agents; Quinoxalines; Rats; Rats, Wistar; Receptors, AMPA; Sodium Chloride Symporter Inhibitors | 1998 |